Hereditary ataxia – Treatment

Go back

Hereditary ataxia represents a complex group of inherited disorders affecting movement coordination and balance. While there is currently no cure, comprehensive care combining proven therapies with promising research offers hope for improving quality of life and slowing disease progression.

Finding Your Way Through Treatment Options

When someone receives a diagnosis of hereditary ataxia, understanding the treatment landscape becomes crucial for managing expectations and planning ahead. The primary goal of treatment is not to cure the condition, but rather to help maintain function, reduce symptoms, and support the best possible quality of life for as long as possible. Each person’s treatment journey will look different because hereditary ataxias vary widely in how they progress and which symptoms appear first.[1]

Treatment approaches depend heavily on the specific type of ataxia diagnosed, when symptoms first appeared, and how quickly the condition is progressing. Some forms of hereditary ataxia begin in childhood, while others don’t show symptoms until adulthood, sometimes not until age 30 or beyond. This variation means that a teenager with Friedreich ataxia will have different needs than an adult with spinocerebellar ataxia.[2]

Current medical care for hereditary ataxia involves both established treatments approved by healthcare authorities and newer experimental therapies being tested in clinical trials. Standard treatments focus on managing symptoms as they arise, while research studies explore whether certain medications or interventions can slow down or modify the disease process itself. Understanding both options helps families make informed decisions about care.[8]

Standard Treatment Approaches

The foundation of hereditary ataxia care rests on symptomatic treatment, which means addressing each problem as it develops rather than targeting the underlying genetic cause. This approach requires a team of healthcare professionals working together, including neurologists, physiotherapists, speech therapists, occupational therapists, and sometimes cardiologists or other specialists depending on which body systems are affected.[9]

Physical therapy represents one of the most important ongoing treatments for people with hereditary ataxia. Regular physiotherapy helps maintain muscle strength, prevent muscles from becoming stuck in one position (called contractures), and improve balance and coordination for as long as possible. A physiotherapist designs specific exercises targeting the person’s particular challenges, whether that’s walking stability, hand coordination, or core strength. These exercises need to be performed regularly, often daily, to maintain their benefit.[9]

When muscles become stiff, tight, or experience painful spasms, muscle relaxant medications can provide relief. Baclofen and tizanidine are commonly prescribed medications that work by reducing excessive muscle contractions. If these oral medications don’t adequately control spasms, doctors may recommend injections of botulinum toxin (commonly known as Botox) directly into the affected muscles. These injections block the signals from nerves to muscles, reducing spasm and stiffness for approximately three months before requiring repeat treatment.[9]

⚠️ Important
For certain rare types of hereditary ataxia, specific dietary treatments can make a significant difference. Ataxia with vitamin E deficiency can be managed with vitamin E supplements, while cerebrotendinous xanthomatosis responds to specific bile acid replacement therapy. Always ask your neurologist whether your specific ataxia type has any treatable metabolic component.

Speech and swallowing difficulties require specialized attention from speech and language therapists. For slurred or unclear speech (called dysarthria), therapists teach techniques to improve voice clarity, such as adjusting posture, practicing breathing exercises, and deliberately slowing speech to emphasize each word. When speech becomes severely affected, therapists can introduce communication aids like laptop computers with voice synthesizers.[9]

Swallowing problems, known as dysphagia, pose serious health risks because food or liquid can enter the lungs instead of the stomach, potentially causing pneumonia. Speech therapists teach exercises that strengthen swallowing muscles and stimulate the nerves responsible for triggering the swallow reflex. Dietitians work alongside therapists to modify food textures, making them easier and safer to swallow while maintaining adequate nutrition.[9]

Eye movement abnormalities, particularly involuntary side-to-side or up-and-down movements called oscillopsia, can make reading and other visual tasks extremely challenging. The medication gabapentin sometimes helps control the muscles that move the eyes, reducing this disruptive symptom. Other eye problems may require different approaches, and regular monitoring by eye specialists helps catch and address issues early.[9]

Bladder control issues affect many people with hereditary ataxia. Some experience urgent needs to urinate frequently, while others struggle to empty the bladder completely. Initial management often involves lifestyle adjustments: limiting fluid intake during certain times, scheduling regular bathroom visits, and avoiding drinks that stimulate urine production like caffeine and alcohol. When behavioral strategies aren’t sufficient, medications called antimuscarinic drugs can relax the bladder, reducing urgency. In some cases, botulinum toxin injections into the bladder or the use of a urinary catheter (a thin tube inserted to drain urine) becomes necessary.[9]

Occupational therapy helps people adapt to progressive loss of mobility and develop new skills for managing daily activities. Occupational therapists assess what modifications would help someone remain as independent as possible, whether that means learning to use mobility aids like walkers or wheelchairs, or making home modifications such as installing grab rails, ramps, or stair lifts. These adaptations aren’t signs of giving up—they’re tools that preserve energy for activities that matter most.[9]

For Friedreich ataxia specifically, an oral medication called omaveloxolone (brand name Skyclarys) received approval from the U.S. Food and Drug Administration. This represents the first treatment approved specifically for Friedreich ataxia in adults and adolescents aged 16 and older. The medication works by activating cellular pathways that help protect nerve cells from damage. While it doesn’t cure the condition, clinical studies showed it could help slow functional decline.[7]

Emerging Treatments in Clinical Trials

Research into hereditary ataxia treatments continues actively around the world, with numerous clinical trials testing innovative approaches that might one day change how these conditions are managed. Clinical trials happen in phases, each designed to answer specific questions about a new treatment. Phase I trials test whether a treatment is safe and determine appropriate doses. Phase II trials examine whether the treatment shows signs of effectiveness and continue monitoring safety. Phase III trials compare the new treatment against standard care or placebo to definitively determine if it works and is safe enough for widespread use.[8]

One promising research area focuses on medications that target specific molecular pathways involved in hereditary ataxia. For example, researchers are investigating compounds that might protect mitochondria—the energy-producing structures inside cells that are damaged in several forms of ataxia. Coenzyme Q10, idebenone, and other molecules that support mitochondrial function have shown some promise in early studies, particularly for Friedreich ataxia. These substances work by helping cells produce energy more efficiently despite the genetic defects causing the disease.[8]

Gene therapy represents another exciting frontier in ataxia research. This approach involves delivering healthy copies of genes to replace or supplement the faulty genes causing the disease. While still largely experimental for most forms of hereditary ataxia, early animal studies have shown encouraging results. The challenge lies in safely delivering genes to the right cells in the brain and spinal cord, and ensuring they continue working long-term.[8]

Researchers are also testing whether certain medications already approved for other conditions might help with hereditary ataxia symptoms. This approach, called drug repurposing, allows potentially faster paths to treatment since these medications have already proven safe for human use. Various trials have examined medications like riluzole (used for amyotrophic lateral sclerosis), varenicline (used for smoking cessation), and others to see if they improve ataxia symptoms or slow progression.[8]

Clinical trials for hereditary ataxia are conducted at specialized centers around the world, including locations in the United States, Europe, and other regions. Eligibility for participation depends on many factors including the specific type of ataxia, age, disease stage, and other health conditions. Many trials are looking specifically for people early in their disease course, while others seek participants at various stages. Your neurologist can help determine whether any current trials might be appropriate and how to access them.[8]

⚠️ Important
Participating in clinical trials contributes to advancing knowledge about hereditary ataxia even if the treatment being tested doesn’t help you personally. However, trials involve risks and benefits that need careful consideration. Some trials use placebo controls, meaning you might receive an inactive treatment. Always discuss thoroughly with your medical team before enrolling in any research study.

Some research focuses specifically on disease-modifying therapies—treatments that could actually slow down or stop disease progression rather than just managing symptoms. These are particularly important because hereditary ataxias are progressive conditions that worsen over time. While no proven disease-modifying treatment exists yet for most forms of hereditary ataxia, several promising candidates are in various stages of testing. The results from these trials will take years to fully understand, as researchers need to track participants over long periods to see if progression truly slows.[8]

The Role of Rehabilitation and Lifestyle Modifications

Beyond medications and experimental treatments, rehabilitation therapies and lifestyle adjustments play crucial roles in managing hereditary ataxia. Regular exercise, when appropriately designed for someone’s abilities, can help maintain strength, flexibility, balance, and cardiovascular fitness. Studies suggest that people with hereditary ataxia who participate in regular physical activity programs may maintain function longer than those who remain sedentary.[14]

Exercise programs for hereditary ataxia should be individualized and may include activities like yoga for balance and core strength, water-based exercises that reduce fall risk while building strength, and targeted exercises for specific impairments. The key is consistency—doing some form of appropriate physical activity regularly, even if it’s modified as the condition progresses. Working with physiotherapists familiar with ataxia ensures exercises remain safe and beneficial.[14]

Dietary considerations matter for everyone with hereditary ataxia, though their importance varies depending on the specific condition. Maintaining adequate nutrition becomes increasingly important as swallowing difficulties develop. Some people may need nutritional supplements or eventually feeding tubes if eating becomes too difficult or dangerous. For the rare forms of ataxia with metabolic components, specific dietary modifications or supplements can significantly impact the disease course.[14]

Mental health support represents an often-overlooked but essential component of comprehensive ataxia care. Living with a progressive, incurable condition naturally affects emotional well-being. Depression, anxiety, and adjustment disorders are common among people with hereditary ataxia and their family members. Counseling, support groups, and sometimes psychiatric medications can help manage these psychological challenges. Connecting with others who understand the experience through patient organizations or online communities provides valuable emotional support.[12]

Most common treatment methods

  • Physical and Occupational Therapy
    • Regular physiotherapy exercises to maintain muscle strength and prevent contractures
    • Balance and coordination training programs
    • Training in using mobility aids such as walkers, canes, and wheelchairs
    • Home modification recommendations including grab rails, ramps, and stair lifts
    • Exercises targeting specific problems like core stability and hand coordination
  • Speech and Swallowing Therapy
    • Techniques to improve speech clarity including posture adjustments and breathing exercises
    • Communication aids such as voice synthesizers for severely affected speech
    • Swallowing exercises to strengthen muscles and stimulate swallowing reflexes
    • Dietary texture modifications to reduce choking risk
  • Medications for Symptom Control
    • Muscle relaxants like baclofen and tizanidine for spasticity and spasms
    • Botulinum toxin injections for persistent muscle stiffness or bladder problems
    • Gabapentin for involuntary eye movements
    • Antimuscarinic medications for bladder urgency
    • Omaveloxolone (Skyclarys) specifically approved for Friedreich ataxia
  • Supportive Medical Management
    • Regular cardiac monitoring for types affecting the heart
    • Vision and hearing assessments and corrective devices as needed
    • Management of diabetes or other metabolic complications
    • Nutritional support and feeding tubes when swallowing becomes dangerous
  • Experimental Therapies in Clinical Trials
    • Gene therapy approaches delivering healthy gene copies
    • Mitochondrial support compounds like coenzyme Q10 and idebenone
    • Repurposed medications originally developed for other neurological conditions
    • Disease-modifying therapies aimed at slowing progression

Ongoing Clinical Trials on Hereditary ataxia

  • Study on the Safety of VO659 for Patients with Spinocerebellar Ataxia Types 1, 3, and Huntington’s Disease

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Germany The Netherlands

References

https://www.ncbi.nlm.nih.gov/books/NBK1138/

https://www.nature.com/articles/gim201328

https://www.mayoclinic.org/diseases-conditions/ataxia/symptoms-causes/syc-20355652

https://www.movementdisorders.org/MDS/Resources/Patient-Education/Hereditary-Ataxias.htm

https://www.nhs.uk/conditions/ataxia/symptoms/

https://my.clevelandclinic.org/health/symptoms/17748-ataxia

https://www.mayoclinic.org/diseases-conditions/ataxia/diagnosis-treatment/drc-20355655

https://pmc.ncbi.nlm.nih.gov/articles/PMC6089349/

https://www.nhs.uk/conditions/ataxia/treatment/

https://www.urmc.rochester.edu/conditions-and-treatments/ataxia

https://my.clevelandclinic.org/health/symptoms/17748-ataxia

https://www.ataxia.org/6-tips-to-improve-mental-health-while-living-with-ataxia/

https://www.ataxia.org/tips/

https://pmc.ncbi.nlm.nih.gov/articles/PMC12058870/

https://health.clevelandclinic.org/friedreichs-ataxia-caregiver-tips

https://www.mayoclinic.org/diseases-conditions/ataxia/diagnosis-treatment/drc-20355655

https://www.youtube.com/watch?v=yZcQXdLIKb0

https://ada.com/editorial/living-with-friedreichs-ataxia/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

Is there a cure for hereditary ataxia?

Currently, there is no cure for most forms of hereditary ataxia. Treatment focuses on managing symptoms, maintaining function as long as possible, and improving quality of life. However, a few rare types with metabolic causes can be effectively treated with specific dietary supplements or medications. Additionally, one medication called omaveloxolone has been approved specifically for Friedreich ataxia and may help slow functional decline.

How quickly will hereditary ataxia progress?

The progression rate varies dramatically depending on the specific type of hereditary ataxia and individual factors. Some forms progress very slowly over decades, while others advance more quickly. Friedreich ataxia typically progresses gradually, with many people needing wheelchairs within 10 to 20 years of symptom onset. Spinocerebellar ataxias have varied progression rates depending on the specific genetic subtype. Your neurologist can provide information specific to your diagnosed type, though predicting individual progression remains challenging.

What is the most important treatment for hereditary ataxia?

Physical therapy and regular exercise represent some of the most important ongoing treatments for hereditary ataxia. Consistent physiotherapy helps maintain muscle strength, prevent contractures, improve balance and coordination, and may help slow functional decline. A comprehensive approach involving multiple therapies—including speech therapy, occupational therapy, and symptom-specific medications—provides the best outcomes. The exact combination depends on which symptoms are most prominent.

Can clinical trials help me even if the treatment doesn’t work?

Participating in clinical trials contributes valuable knowledge about hereditary ataxia that may benefit future patients, even if you don’t personally experience improvement. Trials help researchers understand disease progression, identify potential biomarkers, refine outcome measures, and rule out ineffective treatments. However, trials involve both potential benefits and risks that require careful consideration with your medical team before enrollment.

Will I need a wheelchair if I have hereditary ataxia?

Many people with hereditary ataxia eventually need wheelchairs, though the timing varies widely depending on the specific condition and individual progression. For example, many people with Friedreich ataxia begin using wheelchairs within 10 to 20 years of symptom onset, while some types of spinocerebellar ataxia may progress more slowly. Using a wheelchair when appropriate isn’t giving up—it’s a tool that preserves energy, reduces fall risk, and maintains independence for activities that matter most.

🎯 Key takeaways

  • Treatment goals focus on maintaining function, managing symptoms, and preserving quality of life rather than curing the condition
  • A multidisciplinary team approach involving neurologists, therapists, and other specialists provides the most comprehensive care
  • Physical therapy and regular exercise represent cornerstone treatments that may help slow functional decline
  • Four rare types of hereditary ataxia have specific treatable causes requiring dietary or biochemical interventions
  • Omaveloxolone (Skyclarys) is the first FDA-approved medication specifically for Friedreich ataxia
  • Clinical trials are actively testing gene therapies, disease-modifying treatments, and repurposed medications
  • Symptom-specific medications can manage muscle spasms, bladder problems, and eye movement abnormalities
  • Mental health support and connection with patient communities provide crucial emotional resilience